# US 2008/0305121 A1 · Agents for Regulating the Activity of Interferon-Producing Cells

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0305121 A1
- Document ID: US20080305121A1
- Status: Published application
- Kind: A1
- Application number: 11/629,045
- Filed: 2005-09-06
- Published: 2008-12-11
- Earliest claimed: 2004-06-11
- Assignees: Ginkgo Biomedical Research Institute Co., Ltd
- Inventors: Jun Ohkawa; Yumiko Kamogawa
- Web page: https://patentgrep.com/patent/US20080305121A1

## CPC

- G01N 33/5047: {Cells of the immune system}
- A61P 37/02: Immunomodulators
- A61P 37/08: Antiallergic agents (antiasthmatic agents A61P11/06; ophthalmic antiallergics A61P27/14)
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C07K 16/2896: {against molecules with a "CD"-designation, not provided for elsewhere}
- C07K 2317/34: Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

The present invention provides agents for regulating the activity of interferon-producing cells (IPCs), which comprise as active ingredients antibodies that bind to BST2 and/or to its homologues, and methods for regulating IPC activity that use these antibodies. According to the present invention, the ability of IPCs to produce interferons (IFNs) and the number of cells can be directly regulated. The present invention also provides uses of BST2 and/or its homologues as markers for IPC activation. Compounds that regulate IPC activation can be screened using the markers for IPC activation.

## Claims

### Claim 1

An agent for suppressing an activity of an interferon-producing cell, which comprises as an active ingredient an antibody recognizing either or both of BST2 and a homologue thereof.

### Claim 2 (depends on 1)

The agent of claim 1 for suppressing an activity of an interferon-producing cell, wherein the activity of the interferon-producing cell is either or both of the activity of producing interferon and survival of the interferon-producing cell.

### Claim 3 (depends on 2)

The agent of claim 2 for suppressing an activity of an interferon-producing cell, wherein the activity of the interferon-producing cell is the activity of producing interferon, and the interferon is a type 1 interferon.

### Claim 4 (depends on 1)

The agent of claim 1 for suppressing an activity of an interferon-producing cell, wherein the BST2 or homologue thereof is a protein comprising an amino acid sequence selected from the group consisting of SEQ ID NOs: 2, 4, and 6.

### Claim 5 (depends on 4)

The agent of claim 4 for suppressing an activity of an interferon-producing cell, which comprises as an active ingredient an antibody recognizing a protein comprising the amino acid sequence of SEQ ID NO: 4.

### Claim 6 (depends on 4)

The agent of claim 4 for suppressing an activity of an interferon-producing cell, which comprises as an active ingredient an antibody that recognizes all proteins comprising the amino acid sequences of SEQ ID NOs: 2, 4, and 6.

### Claim 7

A method for suppressing an activity of an interferon-producing cell, which comprises the step of contacting the interferon-producing cell with an antibody recognizing either or both of BST2 and a homologue thereof.

### Claim 8 (depends on 5)

The method of claim 5 for suppressing an activity of an interferon-producing cell, wherein the activity of the interferon-producing cell is either or both of the activity of producing interferon and survival of the interferon-producing cell.

### Claim 9

A method for producing an antibody that suppresses an activity of an interferon-producing cell, which comprises the steps of:
(1) administering an animal to be immunized with either or both of BST2 and a homologue thereof, or a fragment thereof as an immunogen;
(2) selecting an antibody-producing cell that produces an antibody recognizing either or both of BST2 and a homologue thereof from the antibody-producing cells of the immunized animal of (1);
(3) culturing the antibody-producing cell selected in (2), or isolating a gene encoding an antibody produced by the antibody-producing cell, and culturing a cell carrying and capable of expressing the gene; and
(4) collecting an antibody that suppresses an activity of an interferon-producing cell from the culture of (3).

### Claim 10 (depends on 9)

The method of claim 9, wherein the immunogen is an interferon-producing cell collected from a human.

### Claim 11

A method for detecting an activated interferon-producing cell, which comprises the step of detecting an indicator substance of the following (a) to (d):
(a) a polynucleotide comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs: 1, 3, and 5;
(b) a polynucleotide comprising a consecutive nucleotide sequence selected from a nucleotide sequence selected from the group consisting of SEQ ID NOs: 1, 3, and 5;
(c) a protein comprising an amino acid sequence selected from the group consisting of SEQ ID NOs: 2, 4, and 6; and
(d) a protein comprising a consecutive amino acid sequence selected from an amino acid sequence selected from the group consisting of SEQ ID NOs: 2, 4, and 6.

### Claim 12

A method for separating an activated interferon-producing cell, which comprises the step of isolating an indicator substance of the following (a) to (d):
(a) a polynucleotide comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs: 1, 3, and 5;
(b) a polynucleotide comprising a consecutive nucleotide sequence selected from a nucleotide sequence selected from the group consisting of SEQ ID NOs: 1, 3, and 5;
(c) a protein comprising an amino acid sequence selected from the group consisting of SEQ ID NOs: 2, 4, and 6; and
(d) a protein comprising a consecutive amino acid sequence selected from an amino acid sequence selected from the group consisting of SEQ ID NOs: 2, 4, and 6.

### Claim 13

A reagent for detecting an activated interferon-producing cell, which comprises an antibody that recognizes a protein comprising an amino acid sequence selected from the group consisting of SEQ ID NOs: 2, 4, and 6.

### Claim 14

A reagent for detecting an activated interferon-producing cell, which comprises an oligonucleotide comprising a nucleotide sequence of at least 15 consecutive nucleotides selected from a nucleotide sequence selected from the group consisting of SEQ ID NOs: 1, 3, and 5.

### Claim 15

A reagent for separating an activated interferon-producing cell, which comprises an antibody that recognizes a protein comprising an amino acid sequence selected from the group consisting of SEQ ID NOs: 2, 4, and 6.

### Claim 16

A method for determining a level of in vivo activation of an interferon-producing cell, which comprises the steps of:
(1) detecting either or both of cells expressing an indicator substance of (a) to (d), and an expression level of the indicator substance in an interferon-producing cell comprised in a sample collected from a living body:
(a) a polynucleotide comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs: 1, 3, and 5;
(b) a polynucleotide comprising a consecutive nucleotide sequence selected from a nucleotide sequence selected from the group consisting of SEQ ID NOs: 1, 3, and 5;
(c) a protein comprising an amino acid sequence selected from the group consisting of SEQ ID NOs: 2, 4, and 6; and
(d) a protein comprising a consecutive amino acid sequence selected from an amino acid sequence selected from the group consisting of SEQ ID NOs: 2, 4, and 6; and
(2) relating either or both of the number of cells or the expression level determined in (1) to an activation level of an interferon-producing cell in a subject.

### Claim 17 (depends on 16)

The method of claim 16, wherein the sample collected from a living body is any selected from the group consisting of a body fluid, skin, synovial tissue, hematopoietic tissue, pus, alveolar lavage fluid, and a biopsy sample that can comprise blood cells.

### Claim 18

A method for detecting an activity of a test substance in regulating the activation of an interferon-producing cell, which comprises the steps of:
(1) contacting an interferon-producing cell with a cell stimulant along with a test substance, or contacting an interferon-producing cell with a cell stimulant before or after contact with a test substance;
(2) determining the expression level of an indicator substance of (a) to (d) in the interferon-producing cell:
(a) a polynucleotide comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs: 1, 3, and 5;
(b) a polynucleotide comprising a consecutive nucleotide sequence selected from a nucleotide sequence selected from the group consisting of SEQ ID NOs: 1, 3, and 5;
(c) a protein comprising an amino acid sequence selected from the group consisting of SEQ ID NOs: 2, 4, and 6; and
(d) a protein comprising a consecutive amino acid sequence selected from an amino acid sequence selected from the group consisting of SEQ ID NOs: 2, 4, and 6; and
(3) comparing the expression level of the indicator substance determined in (2) with that of a control, and detecting an activity of the test substance in enhancing the activation of the interferon-producing cell when the expression level is significantly higher than that of the control, or detecting an activity of the test substance in suppressing the activation of the interferon-producing cell when the expression level is significantly lower than that of the control.

### Claim 19 (depends on 18)

The method of claim 18, wherein the cell stimulant is at least one selected from the group consisting of a virus, a viral component, a bacterial DNA, and an interferon.

### Claim 20 (depends on 18)

A method of screening for a test substance with the activity of regulating the activation of an interferon-producing cell, which comprises the steps of:
(1) measuring an activity of a test substance in regulating the activation of an interferon-producing cell using the method of claim 18; and
(2) selecting a test substance with a strong activity of regulating the activation as compared to a control.

### Claim 21 (depends on 20)

A pharmaceutical composition for regulating an activity of an interferon-producing cell, which comprises as an active ingredient a test substance selected by the method of claim 20.

### Claim 22

A reagent for detecting an activity of regulating the activation of an interferon-producing cell, which comprises an antibody that recognizes a protein comprising an amino acid sequence selected from the group consisting of SEQ ID NOs: 2, 4, and 6.

### Claim 23

A reagent for detecting an activity of regulating the activation of an interferon-producing cell, which comprises an oligonucleotide comprising a nucleotide sequence of at least 15 consecutive nucleotides selected from a nucleotide sequence selected from the group consisting of SEQ ID NOs: 1, 3, and 5.

### Claim 24

A polynucleotide of any one of the following (i) to (vi):
(i) a polynucleotide encoding a protein comprising the amino acid sequence of SEQ ID NO: 4 or 6;
(ii) a polynucleotide comprising a coding region in the nucleotide sequence of SEQ ID NO: 3 or 5;
(iii) a polynucleotide encoding a protein which comprises an amino acid sequence with a substitution, deletion, insertion, and/or addition of one or more amino acids in the amino acid sequence of SEQ ID NO: 4 or 6 and which is functionally equivalent to a protein comprising the amino acid sequence of SEQ ID NO: 2;
(iv) a polynucleotide that hybridizes under stringent conditions to a DNA comprising the nucleotide sequence of SEQ ID NO: 3 or 5;
(v) a polynucleotide encoding the amino acid sequence of position 139 to 158 from the N terminus of the amino acid sequence of SEQ ID NO: 4; and
(vi) a polynucleotide encoding the amino acid sequence of position 96 to 100 from the N terminus of the amino acid sequence of SEQ ID NO: 6.

### Claim 25 (depends on 24)

A protein comprising an amino acid sequence encoded by the polynucleotide of claim 24.

### Claim 26 (depends on 25)

An antibody against the protein of claim 25, which recognizes a region comprising the amino acid sequence of position 139 to 158 from the N terminus of the amino acid sequence of SEQ ID NO: 4.

### Claim 27 (depends on 25)

An antibody against the protein of claim 25, which recognizes a region comprising the amino acid sequence of position 96 to 100 from the N terminus of the amino acid sequence of SEQ ID NO: 6.

### Claim 28 (depends on 26, 27)

The antibody of claim 26 or 27, which is a monoclonal antibody.

### Claim 29 (depends on 24)

A vector comprising the polynucleotide of claim 24.

### Claim 30 (depends on 24)

A transformed cell that carries the polynucleotide of claim 24 or a vector comprising the polynucleotide.

### Claim 31 (depends on 25, 30)

A method for producing the protein of claim 25, which comprises the steps of culturing the transformed cell of claim 30 and collecting the protein of claim 25 from the culture.

### Claim 32

The hybridoma 3D3#7 deposited under FERM-BP-10339, or the hybridoma 3G7#6 deposited under FERM-BP-10340.

### Claim 33

A monoclonal antibody produced by the hybridoma 3D3#7 deposited under FERM-BP-10339 or the hybridoma 3G7#6 deposited under FERM-BP-10340, or a fragment thereof comprising an antigen-binding domain.

### Claim 34

A method for producing a monoclonal antibody or a fragment thereof comprising an antigen-binding domain, which comprises the steps of culturing the hybridoma 3D3#7 deposited under FERM-BP-10339 or the hybridoma 3G7#6 deposited under FERM-BP-10340, and collecting an immunoglobulin from the culture.

### Claim 35

An agent for suppressing an activity of an interferon-producing cell, which comprises as an active ingredient a monoclonal antibody produced by the hybridoma 3D3#7 deposited under FERM-BP-10339 or the hybridoma 3G7#6 deposited under FERM-BP-10340, or a fragment thereof comprising an antigen-binding domain.
